Cumulative hazard of death increased in association with hemorrhagic stroke, but not with ischemic stroke
Hemorrhagic Stroke + COVID-19 Doubles Risk for In-Hospital Mortality
In addition to increased risk for death, hospital and ICU lengths of stay are longer
Toxic Metabolic Encephalopathy Worsens COVID-19 Outcomes
TME was associated with increased risk for in-hospital death, with the highest risk for TME due to hypoxemia
Central Line-Associated Bloodstream Infections Increased in 2020
More infections came as hospitals experienced high numbers of COVID-19 admissions
New Models Predict Risk for Ventilation, Death From COVID-19
Age not a predictor of which hospitalized COVID-19 patients will require ventilation
IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
Tocilizumab Does Not Improve Outcomes in Severe COVID-19
Tocilizumab plus standard care no better for improving clinical outcomes at 15 days and may increase mortality
Mortality Decreased for COVID-19 ICU Patients Over Time
Mortality decreased from 43.5 to 19.2 percent between first and last 15-day periods; no change seen in other patient factors
For COVID-19 ICU Patients, Death Linked to COVID-19 ICU Strain
Mortality increased when COVID-19 ICU demand was >75 to 100 percent for patients treated in COVID-19 ICU
Men More Likely to Test Positive for SARS-CoV-2, Die From COVID-19
During their hospital course, more men than women experience pulmonary and extrapulmonary complications